Literature DB >> 21524898

CD4+ memory T cell survival.

Justin J Taylor1, Marc K Jenkins.   

Abstract

Memory CD4+ T cells specific for a given antigen are generated during the primary response from the effector lymphoblast progeny of naïve precursors. How memory CD4+ T cells differentiate from the effector population is not understood but new tools to assess transcription factor and cytokine expression are allowing for a more careful assessment of this process. Here we review the factors that allow some effector CD4+ T cells to survive the contraction phase of the primary response and become memory cells, and consider whether parallels can be drawn between T and B cells.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21524898     DOI: 10.1016/j.coi.2011.03.010

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  25 in total

1.  A Plasmodium-encoded cytokine suppresses T-cell immunity during malaria.

Authors:  Tiffany Sun; Thomas Holowka; Yan Song; Swen Zierow; Lin Leng; Yibang Chen; Huabao Xiong; Jason Griffith; Mehdi Nouraie; Philip E Thuma; Elias Lolis; Chris J Janse; Victor R Gordeuk; Kevin Augustijn; Richard Bucala
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-09       Impact factor: 11.205

Review 2.  Immune checkpoint dysfunction in large and medium vessel vasculitis.

Authors:  Ryu Watanabe; Hui Zhang; Gerald Berry; Jörg J Goronzy; Cornelia M Weyand
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-03-17       Impact factor: 4.733

3.  Transcriptional regulator Id2 is required for the CD4 T cell immune response in the development of experimental autoimmune encephalomyelitis.

Authors:  Yen-Yu Lin; Mary E Jones-Mason; Makoto Inoue; Anna Lasorella; Antonio Iavarone; Qi-Jing Li; Mari L Shinohara; Yuan Zhuang
Journal:  J Immunol       Date:  2012-06-27       Impact factor: 5.422

4.  CCR7+ central and CCR7- effector memory CD4+ T cells in human cutaneous leishmaniasis.

Authors:  Hossein Keshavarz Valian; Mahmoud Nateghi Rostami; Minoo Tasbihi; Akram Miramin Mohammadi; Seyed Ebrahim Eskandari; Abdolfattah Sarrafnejad; Ali Khamesipour
Journal:  J Clin Immunol       Date:  2012-09-19       Impact factor: 8.317

5.  Th17 cells are long lived and retain a stem cell-like molecular signature.

Authors:  Pawel Muranski; Zachary A Borman; Sid P Kerkar; Christopher A Klebanoff; Yun Ji; Luis Sanchez-Perez; Madhusudhanan Sukumar; Robert N Reger; Zhiya Yu; Steven J Kern; Rahul Roychoudhuri; Gabriela A Ferreyra; Wei Shen; Scott K Durum; Lionel Feigenbaum; Douglas C Palmer; Paul A Antony; Chi-Chao Chan; Arian Laurence; Robert L Danner; Luca Gattinoni; Nicholas P Restifo
Journal:  Immunity       Date:  2011-12-15       Impact factor: 31.745

6.  p27(Kip1) negatively regulates the magnitude and persistence of CD4 T cell memory.

Authors:  Anna Jatzek; Melba Marie Tejera; Anju Singh; Jeremy A Sullivan; Erin H Plisch; M Suresh
Journal:  J Immunol       Date:  2012-10-15       Impact factor: 5.422

7.  Homeostatic division is not necessary for antigen-specific CD4+ memory T cell persistence.

Authors:  Evann Corbo-Rodgers; Karla R Wiehagen; Elizabeth S Staub; Jonathan S Maltzman
Journal:  J Immunol       Date:  2012-09-05       Impact factor: 5.422

8.  Stimulation of HIV-1-specific cytolytic T lymphocytes facilitates elimination of latent viral reservoir after virus reactivation.

Authors:  Liang Shan; Kai Deng; Neeta S Shroff; Christine M Durand; S Alireza Rabi; Hung-Chih Yang; Hao Zhang; Joseph B Margolick; Joel N Blankson; Robert F Siliciano
Journal:  Immunity       Date:  2012-03-08       Impact factor: 31.745

9.  Expanding roles for CD4 T cells and their subpopulations in tumor immunity and therapy.

Authors:  Mark J Dobrzanski
Journal:  Front Oncol       Date:  2013-03-26       Impact factor: 6.244

10.  When Aging Reaches CD4+ T-Cells: Phenotypic and Functional Changes.

Authors:  Marco Antonio Moro-García; Rebeca Alonso-Arias; Carlos López-Larrea
Journal:  Front Immunol       Date:  2013-05-10       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.